-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Solving clinical trial delays: innovative solutions
Kavita Singh, M Abdul Salam, Raji Devarajan & Dorairaj Prabhakaran
Clinical Trail Perspective: Clinical Investigation
-
Solving clinical trial delays: innovative solutions
Kavita Singh, M Abdul Salam, Raji Devarajan & Dorairaj Prabhakaran
Clinical Trail Perspective: Clinical Investigation
-
Solving clinical trial delays: innovative solutions
Kavita Singh, M Abdul Salam, Raji Devarajan & Dorairaj Prabhakaran
Clinical Trail Perspective: Clinical Investigation
-
Solving clinical trial delays: innovative solutions
Kavita Singh, M Abdul Salam, Raji Devarajan & Dorairaj Prabhakaran
Clinical Trail Perspective: Clinical Investigation
-
Solving clinical trial delays: innovative solutions
Kavita Singh, M Abdul Salam, Raji Devarajan & Dorairaj Prabhakaran
Clinical Trail Perspective: Clinical Investigation
-
Solving clinical trial delays: innovative solutions
Kavita Singh, M Abdul Salam, Raji Devarajan & Dorairaj Prabhakaran
Clinical Trail Perspective: Clinical Investigation
-
Solving clinical trial delays: innovative solutions
Kavita Singh, M Abdul Salam, Raji Devarajan & Dorairaj Prabhakaran
Clinical Trail Perspective: Clinical Investigation
-
Solving clinical trial delays: innovative solutions
Kavita Singh, M Abdul Salam, Raji Devarajan & Dorairaj Prabhakaran
Clinical Trail Perspective: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
BRCA status in epithelial ovarian cancer: implications for management and future clinical trial design
Panagiotis A Konstantinopoulos , Ursula A Matulonis
Clinical Trail Methodology: Clinical Investigation
-
BRCA status in epithelial ovarian cancer: implications for management and future clinical trial design
Panagiotis A Konstantinopoulos , Ursula A Matulonis
Clinical Trail Methodology: Clinical Investigation
-
BRCA status in epithelial ovarian cancer: implications for management and future clinical trial design
Panagiotis A Konstantinopoulos , Ursula A Matulonis
Clinical Trail Methodology: Clinical Investigation
-
BRCA status in epithelial ovarian cancer: implications for management and future clinical trial design
Panagiotis A Konstantinopoulos , Ursula A Matulonis
Clinical Trail Methodology: Clinical Investigation
-
BRCA status in epithelial ovarian cancer: implications for management and future clinical trial design
Panagiotis A Konstantinopoulos , Ursula A Matulonis
Clinical Trail Methodology: Clinical Investigation
-
BRCA status in epithelial ovarian cancer: implications for management and future clinical trial design
Panagiotis A Konstantinopoulos , Ursula A Matulonis
Clinical Trail Methodology: Clinical Investigation
-
BRCA status in epithelial ovarian cancer: implications for management and future clinical trial design
Panagiotis A Konstantinopoulos , Ursula A Matulonis
Clinical Trail Methodology: Clinical Investigation
-
BRCA status in epithelial ovarian cancer: implications for management and future clinical trial design
Panagiotis A Konstantinopoulos , Ursula A Matulonis
Clinical Trail Methodology: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
Investigation into the assessment of tobacco use in clinical trials
News and Views: Clinical Investigation
-
Investigation into the assessment of tobacco use in clinical trials
News and Views: Clinical Investigation
-
Investigation into the assessment of tobacco use in clinical trials
News and Views: Clinical Investigation
-
Investigation into the assessment of tobacco use in clinical trials
News and Views: Clinical Investigation
-
Investigation into the assessment of tobacco use in clinical trials
News and Views: Clinical Investigation
-
Investigation into the assessment of tobacco use in clinical trials
News and Views: Clinical Investigation
-
Investigation into the assessment of tobacco use in clinical trials
News and Views: Clinical Investigation
-
Investigation into the assessment of tobacco use in clinical trials
News and Views: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with Mike Kenward
Mike Kenward
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with Mike Kenward
Mike Kenward
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with Mike Kenward
Mike Kenward
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with Mike Kenward
Mike Kenward
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with Mike Kenward
Mike Kenward
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with Mike Kenward
Mike Kenward
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with Mike Kenward
Mike Kenward
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with Mike Kenward
Mike Kenward
Interview: Clinical Investigation
-
News from the European Society of Cardiology Congress 2011
News and Views: Clinical Investigation
-
News from the European Society of Cardiology Congress 2011
News and Views: Clinical Investigation
-
News from the European Society of Cardiology Congress 2011
News and Views: Clinical Investigation
-
News from the European Society of Cardiology Congress 2011
News and Views: Clinical Investigation
-
News from the European Society of Cardiology Congress 2011
News and Views: Clinical Investigation
-
News from the European Society of Cardiology Congress 2011
News and Views: Clinical Investigation
-
News from the European Society of Cardiology Congress 2011
News and Views: Clinical Investigation
-
News from the European Society of Cardiology Congress 2011
News and Views: Clinical Investigation
-
Clinical research in Latin America: obstacles and opportunities
Emmanuel Coronel, Donald Halstead, Felipe Fregni
Editorial: Clinical Investigation
-
Clinical research in Latin America: obstacles and opportunities
Emmanuel Coronel, Donald Halstead, Felipe Fregni
Editorial: Clinical Investigation
-
Clinical research in Latin America: obstacles and opportunities
Emmanuel Coronel, Donald Halstead, Felipe Fregni
Editorial: Clinical Investigation
-
Clinical research in Latin America: obstacles and opportunities
Emmanuel Coronel, Donald Halstead, Felipe Fregni
Editorial: Clinical Investigation
-
Clinical research in Latin America: obstacles and opportunities
Emmanuel Coronel, Donald Halstead, Felipe Fregni
Editorial: Clinical Investigation
-
Clinical research in Latin America: obstacles and opportunities
Emmanuel Coronel, Donald Halstead, Felipe Fregni
Editorial: Clinical Investigation
-
Clinical research in Latin America: obstacles and opportunities
Emmanuel Coronel, Donald Halstead, Felipe Fregni
Editorial: Clinical Investigation
-
Clinical research in Latin America: obstacles and opportunities
Emmanuel Coronel, Donald Halstead, Felipe Fregni
Editorial: Clinical Investigation